Gastroparesis

Journal of Clinical Gastroenterology

Volumn 52, Issue 1, 2017, Pages 20-24

  Lacy, Brian E ^a   Crowell, Michael D ^b   Mathis, Carole ^c   Bauer, David ^d   Heinberg, Leslie J ^e  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

^c JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^d Missoula County Health Dept   (United States)

^e CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

Author keywords

gastric emptying; gastroparesis; health care utilization; quality of life

Indexed keywords

ABDOMINAL PAIN; ACTIVITY OF DAILY LIVING ASSESSMENT; ADULT; AGED; AMBULATORY CARE; ARTICLE; DIAGNOSTIC TEST; EMERGENCY WARD; EMPLOYMENT STATUS; FEMALE; HEALTH CARE UTILIZATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MCGILL PAIN QUESTIONNAIRE; MENTAL HEALTH; PAIN ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; RETURN TO WORK; SHORT FORM 36; SOCIAL INTERACTION; STOMACH PARESIS; WELLBEING; ADOLESCENT; MARYLAND; MIDDLE AGED; PAIN MEASUREMENT; PATIENT ATTITUDE; PROSPECTIVE STUDY; PSYCHOLOGY; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BALTIMORE; FEMALE; GASTROPARESIS; HUMANS; MALE; MIDDLE AGED; PAIN MEASUREMENT; PATIENT ACCEPTANCE OF HEALTH CARE; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84992374734     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0000000000000728     Document Type: Article

References (44)

1. Camilleri M, Parkman HP, Shafi MA, et al. Clinical guideline: management of gastroparesis. Am J Gastroenterol. 2013;108: 18-37.
2. Parkman HP, Hasler WL, Fisher RS, et al. for the American Gastroenterological Association. American Gastroenterological Association medical position statement: diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127: 1589-1591.
3. Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. Am J Gastroenterol. 2000;95:1456-1462.
4. Guo JP, Maurer AH, Fisher RS, et al. Extending gastric emptying Scintigraphy from two to four hours detects more patients with gastroparesis. Dig Dis Sci. 2001;46:24-29.
5. Ziessman HA, Bonta DV, Goetze S, et al. Experience with a simplified, standardized 4-hour gastric emptying protocol. J Nucl Med. 2007;48:568-572.
6. Abell TL, Camilleri M, Donohue K, et al. Consensus recommendations for gastric empting Scintigraphy: A joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine. Am J Gastroenterol. 2008;103:753-763.
7. Soykan I, Sivri B, Sarosiek I, et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998;43:2398-2404.
8. Hoogerwerf WA, Pasricha PJ, Kalloo AN, et al. Pain: The overlooked symptom in gastroparesis. Am J Gastroenterol. 1999;94:1029-1033.
9. Keshavarzian A, Iber FL, Vaeth J. Gastric emptying in patients with insulin-requiring diabetic mellitus. Am J Gastroenterol. 1987;82:29-35.
10. Horowitz M, Maddox AF, Wishart JM, et al. Relationships between oesophageal transit and solid and liquid gastric empting in diabetes mellitus. Eur J Nucl Med. 1991;18:229-234.
11. Jones KL, Russo A, Stevens JE, et al. Predictors of delayed gastric emptying in diabetes. Diabetes Care. 2001;24: 1264-1269.
12. Pande H, Lacy BE, Crowell MD. Inflammatory causes of gastroparesis: report of 5 cases. Dig Dis Sci. 2002;47:2664-2668.
13. Horowitz M, Harding PE, Maddox AF, et al. Gastric and oesophageal emptying in patients with type 2 (noninsulin dependent) diabetes mellitus. Diabetologia. 1989;32: 151-159.
14. Enck P, Rathmann W, Spiekermann M, et al. Prevalence of gastrointestinal symptoms in diabetic patients and non-diabetic subjects. Z Gastroenterol. 1994;32:637-641.
15. Maleki D, Locke GR III, Camilleri M, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med. 2000;160:2808-2816.
16. Bytzer P, Talley NJ, Leemon M, et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: A population-based survey of 15,000 adults. Arch Intern Med. 2001;161:1989-1996.
17. Lacy BE. Functional dyspepsia and gastroparesis: one disease or two? Am J Gastroenterol. 2012;107:1615-1620.
18. Ware JE Jr, Snow KK, Kosinski M, et al. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center; 1993.
19. Revicki DA, Rentz AM, Dubois D, et al. Gastroparesis Cardinal Symptom Index (GCSI): Development and validation of a patient reported assessment of severity of gastroparesis symptoms. Quality Life Res. 2004;13:833-844.
20. Farup CE, Leidy NK, Murray M, et al. Effect of domperidone on the health-related quality of life of patients with symptoms of diabetic gastroparesis. Diabetes Care. 1998;21:1699-1706.
21. Soykan I, Sarosiek I, McCallum RW. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol. 1997;92:976-980.
22. Silvers D, Kipnes M, Broadstone V, et al. Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. Clin Therapeut. 1998;20:438-453.
23. Lin Z, McElhinney C, Sarosiek I, et al. Chronic gastric electrical stimulation for gastroparesis reduces the use of prokinetic and/or antiemetic medications and the need for hospitalizations. Dig Dis Sci. 2005;50:1328-1334.
24. Bell RA, Jones-Vessey K, Summerson JH. Hospitalizations and outcomes for diabetic gastroparesis in North Carolina. South Med J. 2002;95:1297-1299.
25. Wang YR, Fisher RS, Parkman HP. Gastroparesis-related hospitalizations in the United States: Trends, characteristics, and outcomes, 1995-2004. Am J Gastroenterol. 2008;103:313-322.
26. Melzack R. The short-form McGill Pain Questionnaire. Pain. 1987;30:191-197.
27. Ware JE, Kosinski M, Keller S. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, MA: The Health Institute, New England Medical Center; 1994.
28. Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4:353-365.
29. Dimenas E, Glise H, Hallerback B, et al. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol. 1993;28:681-687.
30. Revicki DA, Wood M, Maton PN, et al. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med. 1998;103:252-258.
31. Gralnek IM, Hays RD, Kilbourne A, et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119:654-660.
32. Frank L, Kleinman L, Rentz A, et al. Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther. 2000;24:675-689.
33. Creed F, Ratcliffe J, Fernandez L, et al. Health-related qualify of life and health care costs in severe, refractory irritable bowel syndrome. Ann Intern Med. 2001;134:860-868.
34. El-Serag HB, Talley NJ. Health-related quality of life in functional dyspepsia. Aliment Pharmacol Ther. 2003;18: 387-393.
35. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500-1511.
36. Talley NJ, Gabriel SE, Harmsen WS, et al. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology. 1995;109:1736-1741.
37. Brook RA, Kleinman NL, Choung RS, et al. Functional dyspepsia impacts absenteeism and direct and indirect costs. Clin Gastroenterol Hepatol. 2010;8:498-503.
38. Lacy BE, Weiser KT, Kennedy AT, et al. Functional dyspepsia: The economic impact to patients. Aliment Pharmacol Ther. 2013;38:170-177.
39. Hahn BA, Yan S, Strassels S. Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion. 1999;60:77-81.
40. Dean BB, Aguilar D, Barghout V, et al. Impairment in work productivity and health-related quality of life in patients with IBS. Am J Man Care. 2005;11:S17-S26.
41. Cherian D, Sachdeva P, Fisher RS, et al. Abdominal pain is a frequent symptom of gastroparesis. Clin Gastroenterol Hepatol. 2010;8:676-681.
42. Wahlqvist P, Carlsson J, Stalhammar NO, et al. Validity of a work productivity and activity impairment questionnaire for patients with symptoms of gastro-esophageal reflux disease (WPAI-GERD): results from a cross-sectional study. Value Health. 2002;5:106-113.
43. Reilly MC, Bracco A, Ricci JF, et al. The validity and accuracy of the work productivity and activity impairment questionnaire-irritable bowel syndrome version (WPAI:IBS). Aliment Pharmacol Ther. 2004;20:459-467.
44. Lacy BE, Rosemore J, Corbin D, et al. Physicians' attitudes and practices in the evaluation and treatment of irritable bowel syndrome. Scan J Gastroenterol. 2006;41:892-902.